相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Osteoprotective effects of salidroside in ovariectomized mice and diabetic mice
Xiang-Fan Chen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Novel RAS Inhibitors Poricoic Acid ZG and Poricoic Acid ZH Attenuate Renal Fibrosis via a Wnt/beta-Catenin Pathway and Targeted Phosphorylation of smad3 Signaling
Ming Wang et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2018)
Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation
Hua Chen et al.
PHYTOMEDICINE (2018)
Tetrahydroxystilbene glucoside isolated from Polygonum multiflorum Thunb. demonstrates osteoblast differentiation promoting activity
Yayuan Zheng et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
Preventive effects of Polygonum multiflorum on glucocorticoid-induced osteoporosis in rats
Manru Zhou et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
Effect of the water fraction isolated from Fructus Ligustri Lucidi extract on bone metabolism via antagonizing a calcium-sensing receptor in experimental type 1 diabetic rats
Nan-Nan Sha et al.
FOOD & FUNCTION (2017)
Role of RAS/Wnt/β-catenin axis activation in the pathogenesis of podocyte injury and tubulo-interstitial nephropathy
Lin Chen et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2017)
Renin inhibitor aliskiren exerts beneficial effect on trabecular bone by regulating skeletal renin-angiotensin system and kallikrein-kinin system in ovariectomized mice
Y. Zhang et al.
OSTEOPOROSIS INTERNATIONAL (2016)
Effects of Hot Water Extracts from Polygonum multiflorum on Ovariectomy Induced Osteopenia in Mice
Yun-Ho Hwang et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2016)
Involvement of skeletal renin-angiotensin system and kallikrein-kinin system in bone deteriorations of type 1 diabetic mice with estrogen deficiency
Yan Zhang et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2016)
2,3,5,4′-Tetrahydroxystilbene-2-O-β-D-glucoside exerted protective effects on diabetic nephropathy in mice with hyperglycemia induced by streptozotocin
Guang-Tong Chen et al.
FOOD & FUNCTION (2016)
Diabetes and osteoporosis: cause for concern?
Jakob Starup-Linde et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
Bone mineral density evaluation of patients with type 2 diabetes mellitus
Camli Adil et al.
JOURNAL OF PHYSICAL THERAPY SCIENCE (2015)
Use of Renin-Angiotensin System Inhibitors Is Associated with Reduction of Fracture Risk in Hemodialysis Patients
Suguru Yamamoto et al.
PLOS ONE (2015)
Diabetes and bone: biological and environmental factors
Prisco Piscitelli et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2015)
Bone health in type 1 diabetes: focus on evaluation and treatment in clinical practice
V. V. Zhukouskaya et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2015)
Inhibitory effects of 2,3,4',5-tetrahydroxystilbene-2-O-β-D-glucoside on angiotensin II-induced proliferation of vascular smooth muscle cells
Xu Xiao-le et al.
CHINESE JOURNAL OF INTEGRATIVE MEDICINE (2015)
2,3,4,5-Tetrahydroxystilbene 2-O--D-glucoside prevents vascular endothelial dysfunction in a type 2 diabetic rat model
Yuan Zhang
African Journal of Pharmacy and Pharmacology (2014)
The Indispensable Value of Clinical Trials in the Modernization of Traditional Chinese Medicine: 12 Years' Experience at CUHK and Future Perspectives
Willmann Liang et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2014)
Effects of angiotensin II type 1 receptor blocker on bones in mice with type 1 diabetes induced by streptozotocin
Yan Zhang et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2014)
Tissue renin-angiotensin systems: a unifying hypothesis of metabolic disease
Jeppe Skov et al.
FRONTIERS IN ENDOCRINOLOGY (2014)
Angiotensin II induces the production of MMP-3 and MMP-13 through the MAPK signaling pathways via the AT1 receptor in osteoblasts
Kumiko Nakai et al.
BIOCHIMIE (2013)
The effect of 2,3,4′,5-tetrahydroxystilbene-2-0-β-D glucoside on neointima formation in a rat artery balloon injury model and its possible mechanisms
Xiao-le Xu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
2,3,4′,5-Tetrahydroxystilbene-2-O-β-D-glucoside inhibits angiotensin II-induced cardiac fibroblast proliferation via suppression of the reactive oxygen species-extracellular signal-regulated kinase 1/2 pathway
Wei Zhang et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2012)
Protective effect of tetrahydroxystilbene glucoside against hydrogen peroxide-induced dysfunction and oxidative stress in osteoblastic MC3T3-E1 cells
Jin-Kang Zhang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
2, 3, 5, 4′-Tetrahydroxystilbene-2-O-Beta-D-Glucoside Improves Gastrointestinal Motility Disorders in STZ-Induced Diabetic Mice
Mu-Jun Chang et al.
PLOS ONE (2012)
Reciprocal Roles of Angiotensin II and Angiotensin II Receptors Blockade (ARB) in Regulating Cbfa1/RANKL via cAMP Signaling Pathway: Possible Mechanism for Hypertension-Related Osteoporosis and Antagonistic Effect of ARB on Hypertension-Related Osteoporosis
Xiao-Xu Guan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2011)
Tetrahydroxystilbene glucoside ameliorates diabetic nephropathy in rats Involvement of SIRT1 and TGF-β1 pathway
Cairong Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Angiotensin II accelerates osteoporosis by activating osteoclasts
Hideo Shimizu et al.
FASEB JOURNAL (2008)
Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: Blockade of compensatory renin increase
Zhongyi Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
分享论文
